Literature DB >> 14604286

Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro.

Lingling Hou1, Hua Cao, Dongmei Wang, Guorong Wei, Cixian Bai, Yong Zhang, Xuetao Pei.   

Abstract

Mesenchymal stem cells (MSCs) in human umbilical cord blood are multipotent stem cells that differ from hematopoietic stem cells. They can differentiate in vitro into mesenchymal cells such as osteoblasts and adipocytes. However, differentiation into nonmesenchymal cells has not been demonstrated. Here, we report the isolation, purification, expansion, and differentiation of human umbilical cord blood MSCs into neurocytes in vitro. Cord blood samples were allowed to drain from the end of the cord into glass bottles with 20 U/mL preservative-free heparin. MSCs were isolated from human umbilical cord blood, purified, and expanded in Mesencult medium. Surface antigens of MSCs were analyzed by fluorescence-activated cell sorting (FACS). MSC passages 2,5, and 8 were induced to differentiate into neuron-like cells. Neurofilament (NF) and neuron-specific enolase (NSE) were detected by immunohistochemistry staining. Special Nissl bodies were observed by histochemical analysis. The results showed that 6.6 x 10(5) primary MSCs were expanded for 10 passages to obtain 9.9 x 10(8) MSCs, an increase of approximately 1.5 x 10(3)-fold. FACS results showed that the MSCs did not express antigens CD34, CD11a, and CD11b and expressed CD29 and CD71, an expression pattern identical to that of human bone marrow-derived MSCs. Induction results indicated that approximately 70% of the cells exhibited a typical neuron-like phenotype. Immunohistochemistry staining suggested that induced MSCs of different passages expressed NF and NSE. Special Nissl bodies were obvious in the neuron-like cells. These results suggest that MSCs in human umbilical cord blood are capable of differentiating into neuron-like cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604286     DOI: 10.1007/bf02983804

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Unrelated cord blood transplantation for correction of genetic immunodeficiencies.

Authors:  A H Filipovich
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

2.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

Review 3.  Mesenchymal stem cells: biology and potential clinical uses.

Authors:  R J Deans; A B Moseley
Journal:  Exp Hematol       Date:  2000-08       Impact factor: 3.084

4.  Adult rat and human bone marrow stromal cells differentiate into neurons.

Authors:  D Woodbury; E J Schwarz; D J Prockop; I B Black
Journal:  J Neurosci Res       Date:  2000-08-15       Impact factor: 4.164

Review 5.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

6.  Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies.

Authors:  U H Ziegner; H D Ochs; C Schanen; S A Feig; K Seyama; T Futatani; T Gross; M Wakim; R L Roberts; D J Rawlings; S Dovat; J K Fraser; E R Stiehm
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

7.  Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies.

Authors:  K Ohnuma; K Isoyama; K Ikuta; Y Toyoda; J Nakamura; F Nakajima; M Tsuchida; M Ohira; A Suminoe; T Hara; H Nishihira
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

8.  Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction.

Authors:  J S Reese; O N Koç; S L Gerson
Journal:  J Hematother Stem Cell Res       Date:  1999-10

9.  Prompt and durable hematopoietic reconstitution by unrelated cord blood transplantation in a child with Fanconi anemia.

Authors:  T Yoshimasu; R Tanaka; S Suenobu; H Yagasaki; H Yoshino; T Ueda; H Hisakawa; T Ishii; T Mitsui; Y Ebihara; A Manabe; T Iseki; T Maekawa; T Nakahata; S Asano; K Tsuji
Journal:  Bone Marrow Transplant       Date:  2001-04       Impact factor: 5.483

10.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.

Authors:  S M Devine; A M Bartholomew; N Mahmud; M Nelson; S Patil; W Hardy; C Sturgeon; T Hewett; T Chung; W Stock; D Sher; S Weissman; K Ferrer; J Mosca; R Deans; A Moseley; R Hoffman
Journal:  Exp Hematol       Date:  2001-02       Impact factor: 3.084

View more
  21 in total

Review 1.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

2.  Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.

Authors:  Xin-Qin Kang; Wei-Jin Zang; Li-Jun Bao; Dong-Ling Li; Tu-Sheng Song; Xiao-Li Xu; Xiao-Jiang Yu
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 3.  Evaluation of neural plasticity in adult stem cells.

Authors:  Jeffrey J Ross; Catherine M Verfaillie
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 4.  Tissue engineering: strategies, stem cells and scaffolds.

Authors:  Daniel Howard; Lee D Buttery; Kevin M Shakesheff; Scott J Roberts
Journal:  J Anat       Date:  2008-04-15       Impact factor: 2.610

Review 5.  Reviewing and updating the major molecular markers for stem cells.

Authors:  Raquel Calloni; Elvira Alicia Aparicio Cordero; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

6.  Massive Clonal Selection and Transiently Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by Lentiviral RGB-Barcode Technology.

Authors:  Anton Selich; Jannik Daudert; Ralf Hass; Friederike Philipp; Constantin von Kaisenberg; Gabi Paul; Kerstin Cornils; Boris Fehse; Susanne Rittinghausen; Axel Schambach; Michael Rothe
Journal:  Stem Cells Transl Med       Date:  2016-03-31       Impact factor: 6.940

7.  Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.

Authors:  Bikul Das; Roula Antoon; Rika Tsuchida; Shamim Lotfi; Olena Morozova; Walid Farhat; David Malkin; Gideon Koren; Herman Yeger; Sylvain Baruchel
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  Adipose stem cells as alternatives for bone marrow mesenchymal stem cells in oral ulcer healing.

Authors:  Lobna Abdel Aziz Aly; Hala El- Menoufy; Alyaa Ragae; Laila Ahmed Rashed; Dina Sabry
Journal:  Int J Stem Cells       Date:  2012-11       Impact factor: 2.500

9.  Epidermal growth factor promotes the differentiation of stem cells derived from human umbilical cord blood into neuron-like cells via taurine induction in vitro.

Authors:  Wei Jin; Yi-qiao Xing; An-huai Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-02-27       Impact factor: 2.416

Review 10.  Mesodermal fate decisions of a stem cell: the Wnt switch.

Authors:  L A Davis; N I Zur Nieden
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.